Critical Lipid Species in the Hepatovirus Lifecycle

肝病毒生命周期中的关键脂质种类

基本信息

  • 批准号:
    10530593
  • 负责人:
  • 金额:
    $ 51.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-12-12 至 2024-11-30
  • 项目状态:
    已结题

项目摘要

PROJECT ABSTRACT Hepatitis A virus (HAV) is an unusual picornavirus (genus Hepatovirus) that is released without lysis from infected hepatocytes within small extracellular vesicles (EVs) resembling exosomes. These membrane-cloaked virions, or `quasi-enveloped' HAV (eHAV), lack virus-encoded glycoprotein peplomers on their surface, yet they are infectious and the only form of the virus found circulating in the blood of persons with acute hepatitis A. Numerous other `non-enveloped' viruses have been found to be released from cells as quasi-enveloped virions in EVs of varying size, making studies of eHAV relevant to a broad range of viral pathogens. This application proposes to investigate two aspects of lipid metabolism found to be essential for productive hepatovirus infection in a genome-wide forward genetic screen, and will test the following hypotheses: (i) that GD3 and possibly other gangliosides play a crucial role in cellular entry and the initiation of infection by both naked HAV and quasi- enveloped eHAV, by binding to and possibly triggering uncoating of the capsid within late endosomes or endolysosomes, and (ii) that HAV-infected cells and quasi-enveloped eHAV virions are highly enriched in sphingolipids with very long-chain fatty acid (VLCFA, C≥22) tails, and that VLCFA synthesis is required for efficient production and release of infectious eHAV. In Aim 1, exceptional lipidomics expertise will be brought to bear on the question of which ganglioside species are necessary and sufficient for HAV and eHAV to enter cells and initiate infection, and will define the carbohydrate headgroups and acyl tail structures that are optimal for restoring the capacity of virus to infect CRISPR-derived ceramide glucosyltransferase (UGCG) knockout cells. The proposed experiments will also determine the impact of UGCG knockout on endocytosis and intracellular trafficking of HAV and eHAV, and the subcellular localization of exogenous gangliosides that restore the capacity of virus to enter these cells and initiate infection. Aim 2 will identify which ganglioside classes bind specifically to the naked HAV capsid, and whether ganglioside binding destabilizes its structure, lessening its thermostability at neutral or acidic pH, as a surrogate measure of uncoating. Aim 3 will characterize the role played by VLCFA in the hepatovirus lifecycle, and determine the degree to which VLCFA are enriched in infected cells, and in eHAV virions versus non-viral exosomes, and whether VLCFA are required for the production and cellular release of infectious eHAV, or for assembly of replication organelles involved in the synthesis of viral RNA. Additional experiments will determine whether and how HAV infection upregulates VLCFA synthetic flux, and whether this is essential for productive infection. By studying the role of lipids in hepatovirus replication, the proposed research will address an unexplored and neglected facet of the pathobiology of this important human pathogen.
项目摘要 甲型肝炎病毒(HAV)是一种不常见的小核糖核酸病毒(肝病毒属), 类似于外来体的小细胞外囊泡(EV)内的肝细胞。这些披着膜的病毒体 或“准包膜”HAV(eHAV),在其表面上缺乏病毒编码的糖蛋白peplomer,但它们是 具有传染性,也是在急性甲型肝炎患者血液中循环的唯一病毒形式。许多 已经发现其它"无包膜"病毒在以下EV中作为准包膜病毒体从细胞释放: 不同的大小,使eHAV的研究与广泛的病毒病原体有关。本申请建议 研究了在一个人中发现对生产性肝病毒感染至关重要的脂质代谢的两个方面, 全基因组正向遗传筛选,并将测试以下假设:(i)GD3和可能的其他 神经节苷脂在裸HAV和准HAV的细胞进入和感染起始中起关键作用, 包膜eHAV,通过结合并可能触发晚期内体内衣壳的脱壳,或 内溶酶体,和(ii)HAV感染的细胞和准包膜eHAV病毒粒子高度富集 具有极长链脂肪酸(VLCFA,C ≥ 22)尾鞘脂,VLCFA合成是 有效生产和释放传染性eHAV。在目标1中,将把卓越的脂质组学专业知识带到 关于HAV和eHAV进入细胞所必需和充分的神经节苷脂种类的问题 并启动感染,并定义最适合的碳水化合物头部和酰基尾部结构 恢复病毒感染CRISPR衍生的神经酰胺葡糖基转移酶(UGCG)敲除细胞的能力。 所提出的实验还将确定UGCG敲除对内吞作用和细胞内分泌的影响。 HAV和eHAV的运输,以及恢复HAV和eHAV的能力的外源性神经节苷脂的亚细胞定位。 病毒进入这些细胞并开始感染。目的2将确定哪些神经节苷脂类特异性结合 裸露的HAV衣壳,以及神经节苷脂结合是否使其结构不稳定,降低其热稳定性 在中性或酸性pH下,作为脱涂层的替代测量。目标3将描述VLCFA所发挥的作用 在肝病毒生命周期中,并确定VLCFA在感染细胞中富集的程度, eHAV病毒粒子与非病毒外泌体,以及VLCFA是否是生产和细胞增殖所必需的。 感染性eHAV的释放,或参与病毒RNA合成的复制细胞器的组装。 另外的实验将确定HAV感染是否以及如何上调VLCFA合成通量, 这是否是生产性感染所必需的。通过研究脂质在肝病毒复制中的作用, 拟议的研究将解决这一重要人类疾病病理生物学的一个未探索和被忽视的方面。 病原体

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stanley M. Lemon其他文献

Hepatitis Viruses
  • DOI:
    10.1007/978-1-4615-0881-6
  • 发表时间:
    2002
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Stanley M. Lemon
  • 通讯作者:
    Stanley M. Lemon
A simple method for clonal selection of hepatitis A virus based on recovery of virus from radioimmunofocus overlays.
一种基于从放射免疫聚焦覆盖物中回收病毒的甲型肝炎病毒克隆选择的简单方法。
  • DOI:
    10.1016/0166-0934(85)90040-0
  • 发表时间:
    1985
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Stanley M. Lemon;Robert W. Jansen
  • 通讯作者:
    Robert W. Jansen
Ins and outs of picornaviruses
小 RNA 病毒的来龙去脉
  • DOI:
    10.1038/nature21116
  • 发表时间:
    2017-01-11
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Kevin L. McKnight;Stanley M. Lemon
  • 通讯作者:
    Stanley M. Lemon
7. mRNA for selenoprotein P, a hepatokine, binds RIG-I protein and inhibits the RIG-I-mediated type I interferon response
7. 硒蛋白 P(一种肝因子)的 mRNA 结合 RIG-I 蛋白并抑制 RIG-I 介导的 I 型干扰素反应
  • DOI:
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kazuhisa Murai;Masao Honda;Tetsuro Shimakami;Takayoshi Shirasaki;Hirofumi Misu;Toshinari Takamura;Stanley M. Lemon;Seishi Murakami;Shuichi Kaneko
  • 通讯作者:
    Shuichi Kaneko
Integrin beta 1 facilitates non-enveloped hepatitis E virus cell entry through the recycling endosome
整合素β1通过回收内体促进非包膜戊型肝炎病毒进入细胞
  • DOI:
    10.1038/s41467-025-61071-y
  • 发表时间:
    2025-06-26
  • 期刊:
  • 影响因子:
    15.700
  • 作者:
    Rebecca Fu;Paula Jordan;Zoe Engels;Jasmin Alara Weihs;Josias Mürle;Huanting Chi;Sebastian Burbano de Lara;Barbara Helm;Mara Klöhn;Jungen Hu;Andrew Freistaedter;Tobias Boettler;Marco Binder;Ursula Klingmüller;Eike Steinmann;Pierre-Yves Lozach;Thibault Tubiana;Stanley M. Lemon;Viet Loan Dao Thi
  • 通讯作者:
    Viet Loan Dao Thi

Stanley M. Lemon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stanley M. Lemon', 18)}}的其他基金

Critical Lipid Species in the Hepatovirus Lifecycle
肝病毒生命周期中的关键脂质种类
  • 批准号:
    10306348
  • 财政年份:
    2019
  • 资助金额:
    $ 51.68万
  • 项目类别:
Critical Lipid Species in the Hepatovirus Lifecycle
肝病毒生命周期中的关键脂质种类
  • 批准号:
    9913862
  • 财政年份:
    2019
  • 资助金额:
    $ 51.68万
  • 项目类别:
Novel Pathogen Recognition Pathways and Control of Hepatitis A Virus
新的病原体识别途径和甲型肝炎病毒的控制
  • 批准号:
    9233911
  • 财政年份:
    2014
  • 资助金额:
    $ 51.68万
  • 项目类别:
Membrane Hijacking: Biogenesis and Fate of Enveloped Hepatovirus
膜劫持:包膜肝病毒的生物发生和命运
  • 批准号:
    8549949
  • 财政年份:
    2012
  • 资助金额:
    $ 51.68万
  • 项目类别:
Membrane Hijacking: Biogenesis and Fate of Quasi-Enveloped Hepatovirus
膜劫持:准包膜肝病毒的生物发生和命运
  • 批准号:
    9764230
  • 财政年份:
    2012
  • 资助金额:
    $ 51.68万
  • 项目类别:
Murine Model of HCV-Associated Human Liver Cancer
HCV 相关人类肝癌的小鼠模型
  • 批准号:
    8625280
  • 财政年份:
    2012
  • 资助金额:
    $ 51.68万
  • 项目类别:
Membrane Hijacking: Biogenesis and Fate of Quasi-Enveloped Hepatovirus
膜劫持:准包膜肝病毒的生物发生和命运
  • 批准号:
    10223138
  • 财政年份:
    2012
  • 资助金额:
    $ 51.68万
  • 项目类别:
Murine Model of HCV-Associated Human Liver Cancer
HCV 相关人类肝癌小鼠模型
  • 批准号:
    8219397
  • 财政年份:
    2012
  • 资助金额:
    $ 51.68万
  • 项目类别:
Membrane Hijacking: Biogenesis and Fate of Enveloped Hepatovirus
膜劫持:包膜肝病毒的生物发生和命运
  • 批准号:
    8420039
  • 财政年份:
    2012
  • 资助金额:
    $ 51.68万
  • 项目类别:
Murine Model of HCV-Associated Human Liver Cancer
HCV 相关人类肝癌小鼠模型
  • 批准号:
    8464678
  • 财政年份:
    2012
  • 资助金额:
    $ 51.68万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 51.68万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 51.68万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.68万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.68万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 51.68万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.68万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 51.68万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 51.68万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 51.68万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.68万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了